Kura Oncology (KURA) Notes Payables (2010 - 2014)
Kura Oncology (KURA) reported Notes Payables of $2.0 million for Q4 2014, up 1750.91% year-over-year from $110000.0 in Q4 2013, and up 1528.8% quarter-over-quarter from $125000.0 in Q3 2014.
Kura Oncology (KURA) Notes Payables (2010 - 2014) Analysis & Trends
Kura Oncology (KURA) has 5 years of Notes Payables data on file, last reported at $2.0 million in Q4 2014.
- Notes Payables for Q4 2014 came in at $2.0 million, up 1750.91% year-over-year; the trailing twelve-month figure through Dec 2014 was $2.0 million (up 1750.91% YoY), and the FY2014 annual result was $2.0 million, up 1750.91% from the prior year.
- Notes Payables improved to $2.0 million in Q4 2014 per KURA's latest filing, from $125000.0 in the prior quarter.
- Over five years, Notes Payables peaked at $2.0 million in Q4 2014 and troughed at $60000.0 in Q4 2010.
- A 5-year average of $202117.6 and a median of $85000.0 in 2012 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2011 and 2014: Notes Payables changed 0.0% in 2011, then surged 1750.91% in 2014.
- A 5-year view of Notes Payables shows it stood at $60000.0 in 2010, then changed by 0.0% to $60000.0 in 2011, then jumped by 41.67% to $85000.0 in 2012, then climbed by 29.41% to $110000.0 in 2013, then surged by 1750.91% to $2.0 million in 2014.
- Business Quant data shows KURA's Notes Payables at $2.0 million in Q4 2014, $125000.0 in Q3 2014, and $110000.0 in Q2 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Kura Oncology | 883.44 Mn | 883.44 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 2.04 Mn |
| Sep 30, 2014 | 125,000.00 |
| Jun 30, 2014 | 110,000.00 |
| Mar 31, 2014 | 110,000.00 |
| Dec 31, 2013 | 110,000.00 |
| Sep 30, 2013 | 110,000.00 |
| Jun 30, 2013 | 110,000.00 |
| Mar 31, 2013 | 85,000.00 |
| Dec 31, 2012 | 85,000.00 |
| Sep 30, 2012 | 85,000.00 |
| Jun 30, 2012 | 85,000.00 |
| Mar 31, 2012 | 85,000.00 |
| Dec 31, 2011 | 60,000.00 |
| Sep 30, 2011 | 60,000.00 |
| Jun 30, 2011 | 60,000.00 |
| Mar 31, 2011 | 60,000.00 |
| Dec 31, 2010 | 60,000.00 |